177Lu-PSMA-617
Novartis
['pcsm', 'prostate', 'bayer']
#asco23: trial in progress update from the duet study, in patients with bone-metastatic, oligo-metastatic, hormone-sensitive #prostatecancer after curative therapy abstract tps5113, poster session #pcsm
Driving innovation in cancer care for patients.

By following this account you confirm that you are an HCP & accept our community guidelines: https://t.co/iYZUrNHHuk